The Trump Administration is apparently poised to test nationalhealth-care initiatives with the federal workforce.

The administration has contacted insurance vendors thatparticipate in the Federal Employees Health Benefits Program,informing them that they will be expected to address general healthinsurance cost containment, prescription drug costs,genetic testing and opioid abuse in the health plans they offer fornext year.

These measures were outlined in the federal Office of PersonnelManagement’s annual call letter to insurers. While the letteressentially echoed objectives cited by the Obama Administration,its directives for the 2019 coverage year underscored the fact thatsuch issues have become both nonpartisan and national.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Dan Cook

Dan Cook is a journalist and communications consultant based in Portland, OR. During his journalism career he has been a reporter and editor for a variety of media companies, including American Lawyer Media, BusinessWeek, Newhouse Newspapers, Knight-Ridder, Time Inc., and Reuters. He specializes in health care and insurance related coverage for BenefitsPRO.